JP2024521415A5 - - Google Patents
Info
- Publication number
- JP2024521415A5 JP2024521415A5 JP2023575821A JP2023575821A JP2024521415A5 JP 2024521415 A5 JP2024521415 A5 JP 2024521415A5 JP 2023575821 A JP2023575821 A JP 2023575821A JP 2023575821 A JP2023575821 A JP 2023575821A JP 2024521415 A5 JP2024521415 A5 JP 2024521415A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209941P | 2021-06-11 | 2021-06-11 | |
| US63/209,941 | 2021-06-11 | ||
| PCT/US2022/032956 WO2022261405A1 (en) | 2021-06-11 | 2022-06-10 | Anti-upar antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521415A JP2024521415A (ja) | 2024-05-31 |
| JP2024521415A5 true JP2024521415A5 (https=) | 2025-06-18 |
| JPWO2022261405A5 JPWO2022261405A5 (https=) | 2025-06-18 |
Family
ID=84425502
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575821A Pending JP2024521415A (ja) | 2021-06-11 | 2022-06-10 | 抗ｕＰＡＲ抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240117066A1 (https=) |
| EP (1) | EP4352107A4 (https=) |
| JP (1) | JP2024521415A (https=) |
| CN (1) | CN117693529A (https=) |
| AU (1) | AU2022288937A1 (https=) |
| CA (1) | CA3221895A1 (https=) |
| WO (1) | WO2022261405A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4610269A1 (en) | 2024-02-29 | 2025-09-03 | 3B Pharmaceuticals GmbH | Urokinase plasminogen activator surface receptor (upar) ligands for diagnostic or therapeutic use |
| CN121248786A (zh) * | 2025-12-08 | 2026-01-02 | 上海宏成药业有限公司 | 抗尿激酶纤溶酶原激活物受体抗体及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3504963B2 (ja) * | 1993-10-22 | 2004-03-08 | 智靖 羅 | 抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片 |
| WO2011100620A2 (en) * | 2010-02-12 | 2011-08-18 | The Regents Of The University Of California | Upar binding agents and methods of use thereof |
| WO2013020898A1 (en) * | 2011-08-05 | 2013-02-14 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | Constitutively active upar variants and their use for the generation and isolation of inhibitory antibodies |
| US20170021020A1 (en) * | 2015-07-23 | 2017-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Monoclonal antibody and vaccine targeting filamentous bacteriophage |
| WO2019113248A1 (en) * | 2017-12-07 | 2019-06-13 | The Regents Of The University Of California | Anti-upar antibody-drug conjugates and methods of use thereof |
| AU2020214796A1 (en) * | 2019-01-30 | 2021-07-29 | Truebinding, Inc. | Anti-Gal3 antibodies and uses thereof |
| WO2020160518A1 (en) * | 2019-02-01 | 2020-08-06 | Memorial Sloan Kettering Cancer Center | Senolytic car-t cells targeting upar, a cell surface and secreted senescence biomarker |
-
2022
- 2022-06-10 JP JP2023575821A patent/JP2024521415A/ja active Pending
- 2022-06-10 AU AU2022288937A patent/AU2022288937A1/en active Pending
- 2022-06-10 WO PCT/US2022/032956 patent/WO2022261405A1/en not_active Ceased
- 2022-06-10 CA CA3221895A patent/CA3221895A1/en active Pending
- 2022-06-10 EP EP22821088.6A patent/EP4352107A4/en active Pending
- 2022-06-10 CN CN202280051152.7A patent/CN117693529A/zh active Pending
-
2023
- 2023-12-11 US US18/535,012 patent/US20240117066A1/en active Pending